Aurobindo Pharma (India) Market Value

AUROPHARMA   1,224  6.70  0.55%   
Aurobindo Pharma's market value is the price at which a share of Aurobindo Pharma trades on a public exchange. It measures the collective expectations of Aurobindo Pharma Limited investors about its performance. Aurobindo Pharma is trading at 1223.70 as of the 25th of November 2024, a 0.55 percent increase since the beginning of the trading day. The stock's open price was 1217.0.
With this module, you can estimate the performance of a buy and hold strategy of Aurobindo Pharma Limited and determine expected loss or profit from investing in Aurobindo Pharma over a given investment horizon. Check out Aurobindo Pharma Correlation, Aurobindo Pharma Volatility and Aurobindo Pharma Alpha and Beta module to complement your research on Aurobindo Pharma.
Symbol

Please note, there is a significant difference between Aurobindo Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurobindo Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurobindo Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Aurobindo Pharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aurobindo Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aurobindo Pharma.
0.00
10/26/2024
No Change 0.00  0.0 
In 31 days
11/25/2024
0.00
If you would invest  0.00  in Aurobindo Pharma on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Aurobindo Pharma Limited or generate 0.0% return on investment in Aurobindo Pharma over 30 days. Aurobindo Pharma is related to or competes with Viceroy Hotels, SINCLAIRS HOTELS, Chalet Hotels, Kavveri Telecom, Global Education, Lemon Tree, and Varun Beverages. Aurobindo Pharma is entity of India. It is traded as Stock on NSE exchange. More

Aurobindo Pharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aurobindo Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aurobindo Pharma Limited upside and downside potential and time the market with a certain degree of confidence.

Aurobindo Pharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Aurobindo Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aurobindo Pharma's standard deviation. In reality, there are many statistical measures that can use Aurobindo Pharma historical prices to predict the future Aurobindo Pharma's volatility.
Hype
Prediction
LowEstimatedHigh
1,2061,2071,346
Details
Intrinsic
Valuation
LowRealHigh
1,1121,1141,346
Details
Naive
Forecast
LowNextHigh
1,1931,1951,196
Details
Earnings
Estimates (0)
LowProjected EPSHigh
14.2015.2016.20
Details

Aurobindo Pharma Backtested Returns

Aurobindo Pharma secures Sharpe Ratio (or Efficiency) of -0.3, which signifies that the company had a -0.3% return per unit of risk over the last 3 months. Aurobindo Pharma Limited exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aurobindo Pharma's Mean Deviation of 0.9673, standard deviation of 1.22, and Risk Adjusted Performance of (0.21) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.26, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Aurobindo Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aurobindo Pharma is expected to be smaller as well. At this point, Aurobindo Pharma has a negative expected return of -0.37%. Please make sure to confirm Aurobindo Pharma's skewness, as well as the relationship between the day median price and relative strength index , to decide if Aurobindo Pharma performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.74  

Good predictability

Aurobindo Pharma Limited has good predictability. Overlapping area represents the amount of predictability between Aurobindo Pharma time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aurobindo Pharma price movement. The serial correlation of 0.74 indicates that around 74.0% of current Aurobindo Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient0.74
Spearman Rank Test0.82
Residual Average0.0
Price Variance471.96

Aurobindo Pharma lagged returns against current returns

Autocorrelation, which is Aurobindo Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aurobindo Pharma's stock expected returns. We can calculate the autocorrelation of Aurobindo Pharma returns to help us make a trade decision. For example, suppose you find that Aurobindo Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Aurobindo Pharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aurobindo Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aurobindo Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aurobindo Pharma stock over time.
   Current vs Lagged Prices   
       Timeline  

Aurobindo Pharma Lagged Returns

When evaluating Aurobindo Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aurobindo Pharma stock have on its future price. Aurobindo Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aurobindo Pharma autocorrelation shows the relationship between Aurobindo Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Aurobindo Pharma Limited.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Aurobindo Stock

Aurobindo Pharma financial ratios help investors to determine whether Aurobindo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurobindo with respect to the benefits of owning Aurobindo Pharma security.